Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Third set of concessionary prices announced for August

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following 18 items for August 2018 prescriptions.

Drug
Strength
Form
Price
Hydroxocobalamin
1mg/1ml
solution for injection ampoules (5)
£9.00
Lamotrigine
100mg
tablets (56)
£17.50
Metronidazole
400mg
tablets (21)
£3.30
Mometasone
0.1%
cream (100)
£7.90
Mometasone
0.1%
ointment (30)
£3.45
Mometasone
0.1%
ointment (100)
£8.00
Nebivolol
5mg
tablets (28)
£4.39
Nicorandil
20mg
tablets (60)
£5.00
Oxybutynin
5mg
tablets (56)
£3.65
Ramipril
1.25mg
tablets (28)
£1.75
Ramipril
2.5mg
tablets (28)
£3.90
Ramipril
5mg
tablets (28)
£4.20
Risperidone
1mg
tablets (20)
£3.95
Risperidone
2mg
tablets (60)
£6.00
Sumatriptan
100mg
tablets (6)
£4.50
Topiramate
100mg
tablets (60)
£13.50
Valsartan
80mg
capsules (28)
£10.00
Valsartan
160mg
capsules (28)
£14.73

An initial eight concessionary prices were announced last week (August 20), followed by another 10 three days later.

Do these prices reflect the ones you have paid in August so far?

Related Content

Topics



Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now
UsernamePublicRestriction

Register

CD005494

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel